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FMacrophages are important for effective iron recycling and erythropoiesis, but they also play a crucial
role in wound healing, orchestrating tissue repair. Recently, we demonstrated a signiﬁcant accu-
mulation of iron in healing wounds and a requirement of iron for effective repair. Herein, we sought
to determine the inﬂuence of iron on macrophage function in the context of wound healing.
Interestingly, wound macrophages extensively sequestered iron throughout healing, associated with
a prohealing M2 phenotype. In delayed healing diabetic mouse wounds, both macrophage polari-
zation and iron sequestration were impaired. In vitro studies revealed that iron promotes differen-
tiation, while skewing macrophages toward a hypersecretory M2-like polarization state. These
macrophages produced high levels of chemokine (C-C motif) ligands 17 and 22, promoting wound
reepithelialization and extracellular matrix deposition in a human ex vivo wound healing model.
Together, these ﬁndings reveal a novel, unappreciated role for iron in modulating macrophage
behavior to promote subsequent wound repair. These ﬁndings support therapeutic evaluation of iron
use to promote wound healing in the clinic. (Am J Pathol 2019,-: 1e13; https://doi.org/10.1016/
j.ajpath.2019.07.015)Supported by an MRC (UK) CASE Ph.D. Studentship grant MR/
M016307/1 (M.J.H.) Q5Q6
Q54
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123Macrophages play a crucial role in orchestrating the wound
healing response, fulﬁlling prodigiously versatile functions.1
Evolutionarily conserved receptors allow macrophages to
detect and phagocytose pathogenic organisms in early
repair,2,3 whereas their high plasticity makes them master
effector cells, able to regulate inﬂammation and drive tissue
repair.4 Most, but not all, wound macrophages originate
from circulating bone marrowederived monocytes. Once at
the site of injury, these cells undergo marked, yet transient,
morphologic and behavioral changes in response to the local
wound milieu.5,6 Traditionally, wound-derived macro-
phages are categorized into two main subsets: classically
activated (M1 stimulated) and alternatively activated (M2
stimulated1). However, the M2 repertoire has now
expanded,7 with macrophage polarization currently under-
stood to be a spectrum of phenotypes largely governed by
tissue status and environmental stimuli.8stigative Pathology. Published by Elsevier Inc
LA 5.6.0 DTD  AJPA3195_proof M1-stimulated macrophages are induced in early wound
repair by proinﬂammatory mediators, such as lipopolysac-
charides and interferon-g, driving inﬂammation by secreting
reactive oxygen species and proinﬂammatory cytokines (eg,
IL-1, IL-6, and tumor necrosis factor-a9). Wound progression
is then characterized by a switch to alternative activation (M2),
partly mediated by efferocytosis.10 M2-stimulated macro-
phages express anti-inﬂammatory markers (eg, IL-4, IL-10,
IL-13, and transforming growth factor-b111) and produce
arginase, a key mediator of effective wound repair.12
Furthermore, M2-polarized macrophages produce a myriad
of growth factors to facilitate reepithelialization, ﬁbroplasia,
and angiogenesis.13 Together, these mechanisms promote the. All rights reserved.
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247scavenging of debris, bacteria, and proinﬂammatory cells; and
they orchestrate reparative processes to allow wound
resolution.1
There is a clear existing association between iron and
macrophages in the context of erythropoiesis. Herein,
Kupffer cells and nurse macrophages coordinate iron to
support erythropoiesis,14 and splenic macrophages crucially
recycle iron from senescent erythrocytes.15 As iron is
associated with heme-containing proteins for oxygen
transport and metabolism, iron recycling and regulation by
macrophages prevent a range of iron-mediated pathol-
ogies.16 Indeed, mice with macrophages lacking ferroportin
(the only know intracellular iron exporter) become anemic,
with iron loading in the spleen and liver and defective
macrophage function.17 Thus, iron must be tightly regulated
within the body to maintain normal physiology and avoid
tissue pathology.
In the context of tissue repair, the cellular importance of
iron is less clear. We have recently shown a substantial,
previously unreported, accumulation of iron in the latter
stages of wound healing that is attenuated in pathologic
diabetic wounds.18 This supports preceding observations
that abnormal iron levels are associated with impaired
healing.19,20 Speciﬁcally, iron modulates ﬁbroblast behavior
to promote healing via increased extracellular matrix (ECM)
deposition.18 The hypothesis of the current study is that iron
plays an important role in modulating macrophage behavior
to promote healing. Using a combination of in vitro and
ex vivo studies, we explore the effect of iron on macrophage
polarization, secretory proﬁle, and ability to promote heal-
ing in a human ex vivo wound model. The data demonstrate
an important new role for iron in mediating macrophage
function and subsequent contribution to wound healing.
Materials and Methods
Animal Housing and Experimentation
Young (8- to 10-weekeold) female wild-type (C57/Bl6),
nondiabetic (NDb; Lepr/þ), and diabetic (Db; Lepr/)
mice were purchased from Envigo Ltd (UK) and housed at
the University of Manchester Biological Services Facility.
Mice received food and water ad libitum and were kept
under a 12-hour light/dark cycle with constant temperature
and humidity. Regulated procedures were performed ac-
cording to UK Home Ofﬁce regulations under project li-
cense 70/8136. Two equidistant 6-mm dorsal excisional
wounds were made, as described previously.21 Normal skin
(D0) and excisional wounds were collected and ﬁxed in
neutral-buffered formalin for histology.
Immunohistochemistry Staining
Parafﬁn sections were cut (5 mm thick), dewaxed in xylene,
and brought to water down an ethanol gradient. Antigen
retrieval was performed with citrate buffer (pH 6) before2
FLA 5.6.0 DTD  AJPA3195_proofprimary antibody incubation at 4C overnight. For immu-
noﬂuorescence, anti-rabbit ferritin (clone EPR3004Y),
anti-mouse a-smooth muscle actin (clone 1A4; Abcam,
Cambridge, UK), and anti-rat Mac-3 (clone M3/84; BD
Biosciences, Reading, UK) were used at 5 mg/mL. Anti-
rabbit keratin 14 (clone Poly19053; Biolegend, San Diego,
CA Q), anti-mouse COL1A1 (clone 3G3), and anti-mouse
COL3A1 (clone C-6; Santa Cruz Biotechnology, Heidel-
berg, Germany) were used at 1 mg/mL. Alexa Fluor
488econjugated (Mac-3, a-smooth muscle actin, and
COL1A1) and Alexa Fluor 594econjugated (ferritin, keratin
14, COL1A1, and COL3A1) secondary antibodies were used
at 10 mg/mL for 1 hour at room temperature (all from Thermo
Fisher Scientiﬁc, Paisley, UK). Slides were mounted with
Mowiol 488 (Sigma-Aldrich, Dorset, UK) containing DAPI
(Thermo Fisher Scientiﬁc). Images were taken on an
LSM710 laser scanning confocal microscope (Carl Zeiss Ltd,
Cambridge, UK) using a 20 objective and the 405-nm
diode, 488-nm argon, and 561-nm DPSS Qlasers. Mac-3e,
ferritin-, and a-smooth muscle actinepositive cells were
counted in ImageJ software version 1.8.0 (NIH, Bethesda,
MD; http://imagej.nih.gov/ij). For immunoperoxidase
staining, anti-rat Mac-3 (above), anti-rabbit Nos-2 Q, and anti-
goat arginase-1 antibodies (both from Santa Cruz Biotech-
nology) were used at 1 mg/mL and detected using appropriate
VECTASTAIN ELITE ABC kits and NovaRED peroxidase
substrate (Vector Laboratories, Peterborough, UK). Bright-
ﬁeld images were obtained on a Nikon E400 microscope Q
and SPOT camera (SPOT Imaging, Sterling Heights, MI Q).
Cell counts were performed in ImagePro-Plus version 6.3.0
(Media Cybernetics, Cambridge, UK).
THP-1 Cell Culture
THP-1 cells (ATCC TIB-202; ATCC, Middlesex, UK) were
used as a human monocyte model.22 THP-1 cells were
grown in RPMI 1640 medium (Thermo Fisher Scientiﬁc)
with 10% heat-inactivated fetal bovine serum (Thermo
Fisher Scientiﬁc) and 1% penicillin-streptomycin solution
(Thermo Fisher Scientiﬁc).
THP-1 Cell Differentiation Experiments
Phorbol 12-myristate 13-acetate (PMA) was used at
200 ng/mL to induce differentiation in THP-1 cells. THP-1
cells were treated with or without PMA and iron in the form
of ferric ammonium citrate (FAC) at 10 and 100 mmol/L
concentrations. After 3 days of incubation, THP-1 cells
were collected for RNA (below) to assess the expression of
the differentiation markers, CD11b, CD14, CD36, and
CD54, via quantitative real-time RT-PCR Q(RT-qPCR).23,24
THP-1 Cell Polarization Experiments
After PMA stimulation for 3 days to induce differentiation,
THP-1ederived macrophages (TDMs) were stimulated toajp.amjpathol.org - The American Journal of Pathology
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319M1 (interferon-g and lipopolysaccharide) and M2 (IL-4 and
IL-13) states using reagents at 20 ng/mL concentration (all
from Thermo Fisher Scientiﬁc) or left unstimulated (M0
treatment group). For these polarization experiments, TDMs
were treated with FAC at the same time as adding cytokines.
TDMs were collected after 24 hours for RT-qPCR, immu-
nocytochemistry (using ferritin antibody, as above), and
Western blot analysis.320
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335Quantitative Real-Time RT-PCR
Macrophages were collected in Ambion TRIzol reagent
(Thermo Fisher Scientiﬁc), and RNA was isolated using
phenol/chloroform. RNA was puriﬁed using the Ambion
PureLink Mini Kit (Thermo Fisher Scientiﬁc), as per man-
ufacturer’s instructions, and reverse transcribed with Bio-
script (Bioline, London, UK) and Random Primers
(Promega, Southampton, UK). RT-qPCR was performed
with 2 Takyon SYBR Green mastermix (Eurogentec,
Hampshire, UK) and a CFX Connect thermocycler (Bio-
Rad Laboratories, Hertfordshire, UK). Primer sequences are
provided in Table 1.24
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348Adhesion and Zymography
THP-1 cell adhesion was assessed after PMA and FAC
stimulation (as per differentiation experiments). Herein,
wells were rinsed with Dulbecco’s phosphate-buffered sa-
line (Thermo Fisher Scientiﬁc) to remove nonadherent cells;
and CellTiter 96 AQueous One Solution (Promega) was
added to the wells, as per manufacturer’s guidelines.
Zymography was also performed on conditioned medium
(CM) collected from these THP-1 cells, as described
previously.26Table 1 Primer Sequences for Quantitative Real-time RT-PCR
Gene Forward sequence
hGAPDH* 50-TGCACCACCAACTGCTTAGC-30
hYWHAZ* 50-ACTTTTGGTACATTGTGGCTTCAA
hCD11b 50-AGAACAACATGCCCAGAACC-30
hCD14 50-CGAGGACCTAAAGATAACCGGC-3
hCD36 50-GCCAGTTGGAGACCTGCTTA-30
hCD54 50-GGCTGGAGCTGTTTGAGAAC-30
hCCL17 50-CTTCTCTGCAGCACATCCAC-30
hCCL22 50-TGCCGTGATTACGTCCGTTA-30
hIL-1b 50-CTCGCCAGTGAAATGATGGCT-30
hTNF-a 50-CCAGCTGGAGAAGGGTGAC-30
mGapdh* 50-TGCACCACCAACTGCTTAGC-30
m18s* 50-AGTCCCTGCCTTTGTACACA-30
mCcl17 50-TGCTTCTGGGGACTTTTCTG-30
mCcl22 50-CAGGCAGGTCTGGGTGAA-30
mIl-1b 50-GCCCATCCTCTGTGACTCAT-30
mTnf 50-GAACTGGCAGAAGAGGCACT-30
*Housekeeping genes.
h, human; m, mouse.
The American Journal of Pathology - ajp.amjpathol.org
FLA 5.6.0 DTD  AJPA3195_proof Fibroblast Matrix Preparation
Human skin was collected from theaters at Castle Hill
Hospital (Cottingham, Hull, UK) under LREC Q
(17/SC/0220) approval and full, informed patient consent.
Human dermal ﬁbroblasts (HDFs) were isolated, as previ-
ously described.21 HDFs were cultured in minimum essen-
tial medium (Gibco, Thermo Fisher Scientiﬁc) in 2% fetal
bovine serum with FAC for 11 days. Cells were removed
(denuded) from the HDF-derived ECM with 20 mmol/L
ammonium hydroxide (Sigma-Aldrich) in 0.5% Triton
X-100 in Dulbecco’s phosphate-buffered saline. Denuded
ECM was treated with 10 mg/mL DNAse (Sigma-Aldrich)
and extensively washed. THP-1 cells were seeded on this
HDF-derived ECM with or without 200 ng/mL PMA, left
for 3 days, and collected for differentiation assessment via
RT-qPCR. Immunocytochemistry and Perls Prussian Blue
staining were performed on the HDF-derived ECM.
Ferrozine Assay
A ferrozine assay allowed for the detection of ferrous and
ferric iron.27 Denuded HDF-derived ECMwas scraped on ice
in 50 mmol/L NaOH containing 1%HALT Qprotease inhibitor
cocktail (Thermo Fisher Scientiﬁc). HCl (10 mmol/L) was
added to each lysate with 200 mL iron-releasing reagent
(8.6% v/v HCl and 280 mmol/L KMnO4 in distilled water) for
2 hours at 60C. Standards of known concentrations of FAC
(100mmol/L, 10mmol/L, 1 mmol/L, 100 mmol/L, 10 mmol/L,
1 mmol/L, and 0 mmol/L) were prepared and incubated, as
described. Samples were cooled at room temperature Q, and 50
mL iron detection reagent (650 mmol/L ferrozine, 650 mmol/L
neocuproine, 2.8 mmol/L ammonium acetate, and 1 mmol/L
ascorbic acid in distilled water) was added at room temper-
ature for 30 minutes. Collected supernatant was read at 570Reverse sequence
50-GGCATGGACTGTGGTCATGAG-30
-30 50-CCGCCAGGACAAACCAGTAT-30
50-GCGGTCCCATATGACAGTCT-30
0 50-GTTGCAGCTGAGATCGAGCAC-30
50-CAGCGTCCTGGGTTACATTT-30
50-TCACACTGACTGAGGCCTTG-30
50-AGTACTCCAGGCAGCACTCC-30
50-AAGGTTAGCAACACCACGCC-30
50-GTCGGAGATTCGTAGCTGGAT-30
50-AGGCGTTTGGGAAGGTTG-30
50-GGCATGGACTGTGGTCATGAG-30
50-CATCCGAGGGCCTAACTAAC-30
50-TGGCCTTCTTCACATGTTTG-30
50-TAAAGGTGGCGTCGTTGG-30
50-AGGCCACAGGTATTTTGTCG-30
50-AGGGTCTGGGCCATAGAACT-30
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lated from the FAC standard curve.
Perls Prussian Blue Staining
Perls Prussian Blue staining was used to visualize iron de-
posits. HDFs were left on their deposited ECM or removed
from their ECM before staining. Plates were ﬁxed (4%
formaldehyde solution) and incubated in a 50:50 solution of
5% (w/v) potassium ferricyanide (in distilled water; Sigma-
Aldrich) and 5% (v/v) hydrochloric acid for 10 minutes at
room temperature, then rinsed in distilled water20 before
imaging.
Murine Bone Marrow Macrophage Culture
Bone marrow was isolated from NDb and Db mice with
Dulbecco’s modiﬁed Eagle’s medium (Gibco, Thermo
Fisher Scientiﬁc). Mononuclear phagocytes were differen-
tiated to macrophages with L929 [chemokine (C-C motif)
ligand (CCL)-1; ATCC] CM, containing macrophage
colony-stimulating factor. Macrophages were differentiated
for 7 days, serum starved, and then stimulated. Macro-
phages were left unstimulated (M0) or polarized to M1 or
M2 states21 in the presence of FAC and left for 24 hours
before collecting for RT-qPCR.
Western Blot Analysis
Western blot analysis was performed on FAC-treated
polarized TDMs. Blots were probed with anti-mouse
ferritin (clone B-12; Santa Cruz Biotechnology) at 1
mg/mL concentration for 1 hour at room temperature and
detected with SuperSignal West Pico PLUS Chemilumi-
nescent Substrate (Thermo Fisher Scientiﬁc).
Transwell Co-Culture
THP-1 cells were differentiated and polarized, as described
above, but in Transwell inserts (0.4 mm; Corning, Flintshire,
UK). After polarization, inserts were washed in Dulbecco’s
phosphate-buffered saline, to remove exogenous cytokines
and FAC, and transferred to plates seeded with primary HDFs.
THP-1 cellecontaining inserts were replaced with fresh
inserts after 3 days of culture. On day 6, Transwell inserts were
removed and HDFs were ﬁxed and stained using anti-mouse
collagen type I primary antibody at 1 mg/mL concentration
(clone 3G3; Santa Cruz Biotechnology). Images were taken
via confocal microscopy (above) and analysis of collagen
production performed in ImageJ version 1.8.0. RT-qPCR was
also performed on HDFs after Transwell co-culture.
Proteome Proﬁler Chemokine Arrays
TDMs were polarized in the presence of FAC for 24 hours,
washed extensively, and then given fresh RPMI 1640 media4
FLA 5.6.0 DTD  AJPA3195_proofwith no cytokines for 2 days. This medium was collected
and sterile ﬁltered before performing Proteome Proﬁler
chemokine arrays (Biotechne, Oxford, UK), as per manu-
facturer’s instructions.
Human ex Vivo Wounding
Human skin was collected, as described above, and defatted
before washing in 2% (v/v) antibiotic-antimycotic solution
(Thermo Fisher Scientiﬁc). Partial-thickness wounds were
generated (2-mm diameter) in the center of 6-mmediameter
skin explants using sterile biopsy punches (Stiefel Labora-
tories, Research Triangle Park Q, NC). Wounds were cultured
in Petri dishes on a stack of two absorbent pads and a
nitrocellulose 0.22-mm membrane using Dulbecco’s modi-
ﬁed Eagle’s medium with 10% fetal bovine serum and
1% antibiotic-antimycotic solution. Wounds were treated
with a vehicle (1% bovine serum albumin plus
0.002% dimethyl sulfoxide), 100 nmol/L CCR4 antagonist
(C 021 dihydrochloride), 50 ng/mL CCL17, and/or 50
ng/mL CCL22 (R&D Systems, Oxford, UK), applied topi-
cally every 2 days. Wounds were collected in 4% neutral-
buffered formalin 3 days after wounding for histologic
analysis.
Statistical Analysis
Means  SEM were used to present all data. One- and two-
way analyses of variance were performed where applicable,
with appropriate post-hoc analyses. Signiﬁcance was
deduced at P < 0.05. Statistical analysis was performed in
GraphPad Prism version 7.0 (GraphPad Software, San
Diego, CA Q).
Results
Macrophages Accumulate Iron across a Murine Healing
Time Course
We previously demonstrated the temporal accumulation of
iron in wound repair.18 Herein, the cellular nature of this
accumulated iron (measured as bioavailable ferritin) was
assessed across a wound healing time course. Total ferritin
was signiﬁcantly increased on day 3 (P < 0.001) and day 7
(P < 0.001) after injury (Figure 1, AeC), with a large
proportion of iron sequestration occurring in macrophages
(P < 0.001) (Figure 1D) and, to a lesser extent, a-smooth
muscle actinepositive ﬁbroblasts (P < 0.05) (Figure 1E).
Of note, wound macrophage phenotype changes signiﬁ-
cantly over this time frame; Nos-2epositive (proin-
ﬂammatory) macrophages peaked at day 3 after injury,
whereas arginase-1epositive (anti-inﬂammatory) macro-
phages dominated at day 7 after injury (Supplemental
Figure S1). Hence, wound iron preferentially accumulated
in macrophages, predominately correlating with tissue
inﬁltration of prohealing (M2) macrophages.ajp.amjpathol.org - The American Journal of Pathology
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582Impaired Macrophage Iron Accumulation in Diabetic
Wounds Correlates with Altered Macrophage
Polarization
In both Db and NDb mouse wounds, ferritin increased at
day 3 (P < 0.01 and P < 0.05) and day 7 (P < 0.001 and
P < 0.01) after injury, respectively (Figure 2, A and B).
However, the absolute ferritin level was reduced in Db
mice at all time points examined, signiﬁcant at day 7 after
injury (P < 0.05). Interestingly, although the proportion of
wound tissue ferritin-positive macrophages was approxi-
mately equal between Db and NDb mice day 3 wounds,
there was a clear reduction in Db macrophage iron
sequestration at day 7 after injury (Figure 2C). This
reduced proportion of ferritin-positive macrophages in day
7 Db wounds was even more meaningful given that total
macrophages (Figure 2E) and Nos-2epositive cells (M1
macrophage marker) were both increased in Db mouse
wounds. By contrast, wound arginase-1epositive cells (M2
macrophage marker) were reduced in day 7 Db versus NDb
wounds (P < 0.05) (Figure 2, D and G), mirroring ferritin-
positive macrophages (Figure 2C). Collectively, these dataThe American Journal of Pathology - ajp.amjpathol.org
FLA 5.6.0 DTD  AJPA3195_proof reveal altered macrophage iron sequestration and polari-
zation in Db wounds.
Endogenous Iron or Iron-Rich Extracellular Matrix
Promotes Macrophage Differentiation
The tissue microenvironment drives monocyte to macro-
phage differentiation.5 We, thus, investigated the inﬂuence
of exogenous iron on macrophage differentiation in THP-1
cells in vitro. Herein, iron (100 mmol/L FAC) administration
signiﬁcantly potentiated THP-1 monocyte differentiation in
response to PMA treatment, marked by enhanced expression
of the differentiation markers CD11b (P < 0.001), CD14
(P < 0.001), CD36, and CD54 (P < 0.001) (Figure 3,
AeD). FAC also increased cellular adhesion, a phenotypic
marker of differentiation (P < 0.001) (Figure 3E) and
signiﬁcantly induced cellular MMP-9 Qactivity (P < 0.001)
(Figure 3, F and G).
In the wound environment, macrophages will be exposed
to iron deposited in the ECM; it was, therefore, tested how
ECM derived from FAC-treated HDFs inﬂuenced macro-
phage differentiation. HDFs treated with FAC deposited anFigure 1 Ferritin levels increase in a temporal
manner throughout wound healing, and macro-
phages are key in time-dependent iron sequestra-
tion. A: Full wound images demonstrating ferritin
(red) and a-SMA (green) staining.
DAPI indicates blue nuclei. Five regions in the
granulation tissue were analyzed (white boxed
areas). B: Representative images from red boxed
areas in A. CeE: Ferritin-positive cells (C), ferritin-
positive macrophages (Mac-3; D), and ferritin-
positive ﬁbroblasts [a-smooth muscle actin
(a-SMA); E] increase throughout healing. Signiﬁ-
cance versus day 0 (C) and day 1 (D and E). One-
way analysis of variance with Tukey post-hoc
analysis was performed. Data are expressed as
means þ SEM (CeE). nZ 4 to 5 mice per group ().
*P < 0.05, ***P < 0.001. Scale bars: 100 mm
(A); 50 mm (B) Q35 Q36.
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Figure 2 Diabetic (Db) wound macrophages
show impaired ferritin sequestration and altered
polarization. A: Nondiabetic (NDb) and Db wounds
stained for macrophages (Mac-3; green) and
ferritin (red). DAPI indicates blue nuclei.
Arrows denote ferritin-positive macrophages. B
and C: Quantiﬁcation of total ferritin-positive cells
(B) and ferritin-positive macrophages (C). D:
Immunoperoxidase staining for Nos-2 and
arginase-1. Arrows denote positive staining. EeG:
Quantiﬁcation of wound macrophages (E), Nos-2
epositive macrophages (F) and arginase-1
epositive macrophages (G). B, C, and EeG: P
values (asterisks) are given versus day 0 (B and C)
or day 3 (EeG). Two-way analysis of variance with
Tukey post-hoc analysis was performed. Data are
expressed as means þ SEM (B, C, and EeG). nZ 3
to 5 mice per group (). *P < 0.05, **P < 0.01, and
***P < 0.001; yP < 0.05, yyP < 0.01, and
yyyP < 0.001. Scale bars Z 50 mm () Q37 Q38
Q39 Q40
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743extensive ECM (Figure 3H) rich in iron, as demonstrated by
both Perls Prussian Blue staining (Figure 3I) and ferrozine
assay (Figure 3J). THP-1 monocytes were seeded onto this
denuded ECM and stimulated with PMA to induce differ-
entiation. Exposure to the iron-rich ECM signiﬁcantly
increased expression of the differentiation markers CD11b
(P < 0.001), CD14 (P < 0.05), CD36 (P < 0.001), and
CD54 (Figure 3, KeN). Clearly, both exogenous iron6
FLA 5.6.0 DTD  AJPA3195_prooftreatment and exposure to iron-rich ECM stimulate macro-
phage differentiation.
Iron Drives Cytokine-Stimulated Macrophages Toward a
Prohealing Phenotype
FAC treatment (100 mmol/L) led to a signiﬁcant decrease in
the M1 markers IL-1b (P < 0.01) (Figure 4A) and tumorajp.amjpathol.org - The American Journal of Pathology
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Figure 3 A high iron environment enhances phorbol 12-myristate 13-acetate (PMA)einduced differentiation in THP-1 macrophages (TDMs). TDMs were
treated with ferric ammonium citrate (FAC) at the same time as PMA stimulation for differentiation. AeD: CD11b (A), CD14 (B), CD36 (C), and CD54 (D)
expression [quantitative real-time RT-PCR (RT-qPCR), normalized to no PMA, no FAC group]. EeG: FAC treatment promotes adhesion (E) and MMP-9 activity (F
and G). HeJ: Human dermal ﬁbroblasts (HDFs) deposit extracellular matrix (ECM) high in collagens (green; H) and rich in iron, shown by Perls Prussian Blue Q42
staining (I) and ferrozine assay (J). Arrows indicate blue iron deposits. I: Inset: intracellular iron sequestration. KeN: TDMs seeded onto FAC-treated HDF ECM
display increased expression (RT-qPCR) of differentiation markers. Two-way analysis of variance with Tukey’s post-hoc analysis was performed. Data Q43are
expressed as means þ SEM (AeE, G, and JeN). n Z 3 donors/3 independent experiments (). *P < 0.05, ***P < 0.001 versus control, no FAC group;
yP < 0.05, yyP < 0.01, and yyyP < 0.001. Scale bar Z 50 mm (). A, control; B, 10 mmol/L FAC; C, 100 mmol/L FAC Q41 Q44
Q45 Q46
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Figure 4 Iron skews macrophages toward a prohealing state. THP-1 macrophages were treated with ferric ammonium citrate (FAC) for 24 hours before
quantitative real-time RT-PCR for M1 [IL-1b and tumor necrosis factor (TNF)-a; A and B] and M2 (CCL17 and CCL22; C and D) markers. Nondiabetic (NDb) and
diabetic (Db) macrophage expression of Il-1b (E and I), Tnfa (F and J), Ccl17 (G and K), and Ccl22 (H and L). Normalized to M0, no FAC group. Two-way
analysis of variance with Tukey’s post-hoc analysis was performed. Data are expressed as means þ SEM (AeL). n Z 3 donors/3 independent experiments
(AeL). *P < 0.05, **P < 0.01, and ***P < 0.001 versus M0 group; yP < 0.05, yyP < 0.01, and yyyP < 0.001.
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991necrosis factor-a (P < 0.001) (Figure 4B) in M1-stimulated
TDMs, whereas the expression of the M2 markers CCL17
(P < 0.001) (Figure 4C) and CCL22 (P < 0.001)
(Figure 4D) was elevated in M2-stimulated TDMs after 100
mmol/L FAC. Similar effects were observed in NDb murine
BMDMs, where Il-1b expression was reduced at both FAC
concentrations (P < 0.001) (Figure 4E). Db BMDMs were
less responsive to iron, with Il-1b expression only reduced
by 100 mmol/L FAC treatment (P < 0.05) (Figure 4I).
Intriguingly, 100 mmol/L FAC treatment elevated Ccl17 and
Ccl22 in M0, M1, and M2 polarized BMDMs from NDb
and Db mice (Figure 4, G, H, K, and L). Together, these
data reveal that iron skews cytokine proﬁles in both TDMs
and BMDMs.
Iron-Loaded M2 Macrophages Secrete Factors that
Stimulate Extracellular Matrix Production
TDMs treated with 100 mmol/L FAC showed signiﬁcantly
greater ferritin storage in M0 (P < 0.001) and M2
(P < 0.001) states (Figure 5, A and B) by immunohisto-
chemistry, and in all three activation states via Western blot
analysis (P < 0.01 to P < 0.001) (Figure 5C). For both
techniques, the highest levels of ferritin were observed in8
FLA 5.6.0 DTD  AJPA3195_proof100 mmol/L FACetreated M2-polarized TDMs. As mac-
rophages play a key role in ECM remodeling,28 a Transwell
co-culture approach was used to test the paracrine effects of
FAC-stimulated TDMs on HDF ECM production. Trans-
well co-culture of M2-stimulated FAC-treated TDMs
resulted in up-regulation of COL1A1 (P < 0.05)
(Figure 5D), COL1A2 (P < 0.001) (Figure 5E), and
COL3A1 (P < 0.05) (Figure 5F) expression in HDFs.
Collagen I protein levels were also highest in HDFs
co-cultured with M2-stimulated, FAC-treated TDMs
(P < 0.001) (Figure 5, G and H). Finally, CM from iron-
treated M2-polarized TDMs was proﬁled using chemokine
arrays to characterize secreted factors of interest (Figure 5I).
Herein, CM from M2-stimulated TDMs treated with 100
mmol/L FAC displayed higher levels of multiple chemo-
kines, including CCL17 and CCL22.
CCL17 and CCL22 Promote Healing and ECM Deposition
in Human ex Vivo Wound Repair
To test the biological signiﬁcance of TDM-derived che-
mokines, an ex vivo wound model was used. Given that the
CCL17-CCR4 receptor axis has previously been suggested
to be important for healing,29 CCL17, CCL22, and anajp.amjpathol.org - The American Journal of Pathology
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Figure 5 Iron-loaded THP-1 macrophages (TDMs) secrete factors that stimulate extracellular matrix production in human dermal ﬁbroblasts (HDFs). AeC:
Ferric ammonium citrate (FAC)etreated TDMs show increased ferritin expression via immunocytochemistry (A and B) and Western blot analysis (C).
þFAC indicates 100 mmol/L. DeH: Transwell co-culture of these FAC pretreated TDMs with HDFs leads to up-regulation of COL1A1 (D), COL1A2 (E), and COL3A1
(F) via quantitative real-time RT-PCR, and increased collagen I production via immunoﬂuorescence (G and H), in HDFs. I: Antibody array demonstrates
increased production of chemokines in FAC-treated THP-1econditioned media. Two-way analysis of variance with Tukey’s post-hoc analysis was performed.
Data are expressed þ SEM (BeG). n Z 3 donors/3 independent experiments (). **P < 0.01, ***P < 0.001 versus M0 group; yP < 0.05, yyP < 0.01, and
yyyP < 0.001. Scale bar Z 50 mm (). Q47Q48
Q49Q50
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1115antagonist to their common receptor, CCR4,30 were applied
topically to human ex vivo wounds. Wound closure (re-
epithelialisation) was signiﬁcantly increased after treatment
with CCL17 (P < 0.01) or CCL22 (P < 0.05) in isolation
and by a combination of both ligands (P < 0.001) (Figure 6,
A and B). Although the CCR4 antagonist (C 021 dihydro-
chloride) had no direct effect on wound closure, itThe American Journal of Pathology - ajp.amjpathol.org
FLA 5.6.0 DTD  AJPA3195_proof signiﬁcantly blocked the healing promoting effect of CCL17
(P < 0.05) and a combination of both ligands (P < 0.01).
Finally, CCL17 and CCL22 effects on ECM production
were evaluated. Collagen I and collagen III contents were
assessed from three regions close to the wound surface
(Figure 6C). Collagen I was signiﬁcantly increased after
treatment with CCL17 (P < 0.05) or a combination of both9
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Figure 6 CCL17 and CCL22 promote healing during ex vivo human wound repair. A and B: Keratin 14 staining (KRT14; A) and quantiﬁcation of reepithelialization
(% closure; B). Dotted lines demonstrate reepithelialization. C: Representative image of collagen (COL) immunoﬂuorescence quantiﬁcation from three regions of
each section (boxed areas). DeF: Quantiﬁcation of collagen I and collagen III immunoﬂuorescence (D) and representative immunoﬂuorescence images (E and F).
One-way analysis of variance with Tukey’s post-hoc analysis was performed. Data are expressed as meansþ SEM (B and D). nZ 3 donors (). C021, CCR4 antagonist
(C 021 dihydrochloride) Q51 Q52(). *P < 0.05, **P < 0.01, and ***P < 0.001 vehicle group. Scale barZ 50 mm
Q53
(). C021, CCR4 antagonist (C 021 dihydrochloride).
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1313ligands (P < 0.05), an effect that was again reversed by
cotreatment with the antagonist, C 021 dihydrochloride
(Figure 6, D and E). Collagen III was signiﬁcantly elevated
after treatment with both ligands alone and in combination
(P < 0.05), which was again blocked by the receptor
antagonist, C 021 dihydrochloride (Figure 6, D and F).
Together, these data reveal a novel, previously unappreci-
ated role for the macrophage-derived chemokines, CCL17
and CCL22, in promoting human wound reepithelialization
and matrix deposition.34
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1363Discussion
Macrophages are closely associated with the biological
availability of iron. In addition to modulating heme storage
and erythrocyte recycling,16 they engulf damaged erythro-
cytes in the wound bed.20 Wound tissue macrophages pre-
sent with diverse phenotypes,31 yet how macrophage
behavior is inﬂuenced by the complex wound microenvi-
ronment remains far from clear. Herein, we present new
experimental ﬁndings linking iron modulation of macro-
phage behavior and the remodeling phase of wound repair.
We previously revealed temporal accumulation of iron in
late-stage wound repair.18 Indeed, this wound iron seques-
tration correlates with a macrophage switch to an anti-
inﬂammatory (M2) phenotype,32 which is impaired in Db
pathologic healing.33 Circulating monocytes differentiate
into macrophages in response to environmental cues,5
potentially including iron. In fact, iron deﬁciency reduces
CD14 expression in blood monocyteederived macro-
phage34 and heme iron mediates SPI-Ceinduced macro-
phage differentiation.15 In concurrence, the present study
revealed that exposure to high iron increased macrophage
differentiation, but also signiﬁcantly extended this obser-
vation to demonstrate a role for iron in modulating macro-
phage polarization and chemokine secretion.
Macrophages are able to perform versatile functions with
high plasticity to allow effective repair. Functionally,
CD11b-speciﬁc35 and arginase-speciﬁc12 ablation leads to
delayed healing and excessive inﬂammation. This illustrates
not only the importance of macrophage presence, but also
effective temporal modulation of macrophage phenotype in
wound healing. Although not extensively characterized, the
late-stage M2 switch may be driven by degradation of M1
receptors36 and activation of STAT6 and peroxisome
proliferator-activated receptor-g.37 Herein, we show that
iron may also critically promote alternative activation by
reducing the expression of IL-1b and tumor necrosis factor-
a and up-regulating the expression of CCL17 and CCL22.
The effect of iron on macrophage polarization and
phenotype appears to be context dependent. Heme uptake
by macrophages in the damaged spinal cord promotes M1-
driven inﬂammation in mice,38 whereas iron sequestration
induced an M1 phenotype in raw246.7 macrophages.39 It
has even been suggested that sustained, iron-induced,The American Journal of Pathology - ajp.amjpathol.org
FLA 5.6.0 DTD  AJPA3195_proof proinﬂammatory macrophages may contribute to delayed
healing by triggering ﬁbroblast senescence.40,41 On the
contrary, in atherosclerotic plaques, hemoglobin-
haptoglobin complexes shifted macrophages toward an
M2 state both in vivo (higher CD163) and in vitro (increased
IL-10 and IL-1RA42 Q). Likewise, high iron up-regulated M2
marker expression, and reduced proinﬂammatory cytokines,
in lipopolysaccharide-stimulated macrophages.43
M2 macrophages release a myriad of factors (eg, trans-
forming growth factor-b1) to promote reepithelialization,
ﬁbroplasia, ﬁbroblast differentiation,13 and ECM remodel-
ing.29 In the current study, it is shown, for the ﬁrst time, that
iron treatment of macrophages signiﬁcantly potentiated the
release of a range of chemokines, which promoted collagen
production in HDFs. M2 macrophage CM is known to
stimulate collagen 1 and collagen 3 production in ﬁbroblasts
in vitro,44 but direct application of M2-stimulated BMDMs
did not alter Db healing in vivo.45 These new data suggest
that iron indirectly stimulates HDF ECM deposition via
modulation of macrophage behavior, with potential thera-
peutic application in pathologic healing.
The iron-treated M2 macrophage screen identiﬁed the
chemokines CCL17 and CCL22. Both CCL17 and CCL22
were shown to directly promote reepithelialization and
collagen deposition in a human ex vivo wound repair model.
This is in line with previous work in HaCaTs,46 ﬁbro-
blasts,47 and ﬁbrosis in vivo.48 CCL17 has also been shown
to promote wound closure and granulation tissue formation
in murine wounds in vivo.49 Curiously, Barros et al50
demonstrated improved healing in a CCR4/ type 1 dia-
betes mellitus model and in wild-type type 1 diabetes mel-
litus mice treated with anti-CCL17 and anti-CCL22
antibodies. Thus, future studies investigating macrophage
iron processing should be extended to address tissue- and
pathology-speciﬁc differences.
In summary, these new data demonstrate a key role for
iron in modulating macrophage responses to the wound
environment. Iron skewed macrophages toward an M2-like
state that produced a secretome highly enriched with ECM-
stimulating factors, including the chemokines, CCL17 and
CCL22. It is tempting to speculate that local iron adminis-
tration, perhaps targeted to the latter stages of wound
healing, could have clinical beneﬁt. Further work is now
required to explore how wound iron manipulation can be
used as a conduit to improve skin healing pathology.
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